Quarterly Journal of Nuclear Medicine and Molecular Imaging

Papers
(The TQCC of Quarterly Journal of Nuclear Medicine and Molecular Imaging is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The emerging value of 64Cu for molecular imaging and therapy12
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study10
Lung shunt and lung dose calculation methods for radioembolization treatment planning10
Optimal use of [18F]FDG-PET/CT in patients with fever or inflammation of unknown origin10
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging10
Practice and prospects for PET/CT guided interventions9
Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer9
Adverse effects under immune checkpoint inhibitors on [18F]FDG PET/CT imaging9
An essential practice summary of the new EANM guidelines for parathyroid imaging9
Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors9
Differential diagnostic ability of 18F-FDG PET/CT radiomics features between renal cell carcinoma and renal lymphoma9
Applicability of sentinel lymph node biopsy in papillary thyroid cancer9
Fully integrated [18F]FDG PET/MR in large vessel vasculitis8
The role of PET imaging in inflammatory bowel diseases: state-of-the-art review8
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study8
PSMA uptake on [68Ga]-PSMA-11-PET/CT positively correlates with prostate cancer aggressiveness7
Interventional nuclear medicine: a focus on radioguided intervention and surgery7
IAEA contribution to the development of 64Cu radiopharmaceuticals for theranostic applications7
PET- and SPECT-based navigation strategies to advance procedural accuracy in interventional radiology and image-guided surgery7
Beta radioguided surgery: towards routine implementation?7
Functional and molecular thyroid imaging7
Copper, PET/CT and prostate cancer: a systematic review of the literature6
Radioiodine therapy of Graves' disease6
Molecular imaging of endocrine neoplasms with emphasis on 18F-DOPA PET: a practical approach for well-tailored imaging protocols6
Diagnostic value of positron-emission tomography textural indices for malignancy of 18F-fluorodeoxyglucose-avid adrenal lesions5
[18F]F-Choline PET/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies?5
Therapeutic applications of radioactive sources: from image-guided brachytherapy to radio-guided surgical resection5
18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center5
Update on diagnosis and treatment of hyperthyroidism: ultrasonography and functional imaging5
Integration of molecular imaging in the personalized approach of patients with adrenal masses4
Copper-64 labeled nanoparticles for positron emission tomography imaging: a review of the recent literature4
The role of laboratory medicine in the diagnosis of the hyperthyroidism4
Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization4
18F-FDG PET/CT concurrent with first radioiodine post-therapeutic scan in high risk differentiated thyroid cancer: a useful tool or just an expensive diversion?4
Radioiodine therapy of thyroid autonomy4
Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability?4
Graves' orbitopathy: a multidisciplinary approach3
Radiosynoviorthesis: almost seventy years of experience but still somewhat fameless3
Positron emission tomography-magnetic resonance imaging as a research tool in musculoskeletal conditions3
Theragnostic in neuroendocrine tumors3
The role of PET/CT in thyroid autoimmune diseases3
Detection, resection and cure: a systematic review and meta-analysis of 18F-choline PET in primary hyperparathyroidism3
Contemporary update of SPECT tracers and novelties in radioguided surgery: a perspective based on urology3
Efficient 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based machine learning model for predicting epidermal growth factor receptor mutations in non-small cell lung cancer3
Prognostic value and optimal threshold of first thyroglobulin in low/intermediate risk DTC3
Current approach to surgical management of hyperthyroidism3
Role of 18F-NaF PET/CT in bone metastases3
Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer3
Medical treatment of thyrotoxicosis3
Predictive factors of preoperative sentinel lymph node detection in intermediate and high-risk endometrial cancer3
The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response3
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer3
0.025331974029541